Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Finasteride may cause vitiligo, sexual issues, and depression; better treatments and predicting side effects needed.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

Possible link between COVID-19 and hair loss; more research needed.